Origanum vulgare (oregano) and its Carvacrol Biocomponent as an Alternative of Antimicrobial Agent

Authors

  • Natalia Kaori Aida

  • Janaina Priscila Barbosa

  • Thais Rossini de Oliveira

  • Vanessa da Silva Cardoso

  • Simone Nataly Busato de Feiria

  • Giovana Claudia Boni

  • Jose Francisco Hofling

Keywords:

origanum vulgare; carvacrol; candida spp, streptococcus spp, staphylococcusaureus MRSA

Abstract

The use of plants as an alternative to medicinal treatments is an old practice. The increased resistance of microorganisms to conventional antimicrobials has made studies with medicinal plants increasingly relevant, and ethnobotanical and ethnopharmacological knowledge is considered essential for the development of new drugs. The essential oil of Origanum vulgare and its isolated compound Carvacrol have antimicrobial effects demonstrated in the literature as antibacterial and antifungal activity. Therefore, the present study evaluated the antibacterial and antifungal activity of O. vulgare and Carvacrol using the broth microdilution method (CLSI, 2008), determining MIC (Minimum Inhibitory Concentration) and MFC and MBC (Minimum Fungicidal Concentration and Concentration Minimum Bactericide). Used as standard comparative the antimicrobials Fluconazoleand Chlorhexidine.

How to Cite

Natalia Kaori Aida, Janaina Priscila Barbosa, Thais Rossini de Oliveira, Vanessa da Silva Cardoso, Simone Nataly Busato de Feiria, Giovana Claudia Boni, & Jose Francisco Hofling. (2020). Origanum vulgare (oregano) and its Carvacrol Biocomponent as an Alternative of Antimicrobial Agent. Global Journal of Medical Research, 20(C3), 7–10. Retrieved from https://medicalresearchjournal.org/index.php/GJMR/article/view/2129

Origanum vulgare (oregano) and its Carvacrol Biocomponent as an Alternative of Antimicrobial Agent

Published

2020-05-15